blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2223922

EP2223922 - Inhibitors of human phosphatidyl-inositol 3-kinase delta [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.01.2017
Database last updated on 24.08.2024
Most recent event   Tooltip06.01.2017No opposition filed within time limitpublished on 08.02.2017  [2017/06]
Applicant(s)For all designated states
ICOS Corporation
Lilly Corporate Center
Indianapolis IN 46285 / US
[2015/37]
Former [2010/35]For all designated states
ICOS Corporation
22021 20th Avenue S.E.
Bothell WA 98201 / US
Inventor(s)01 / Sadhu, Chancal
903 223rd Street SE
Bothell, WA 98012 / US
02 / Dick, Ken
22517 1st Place West
Bothell, VA 98021-8321 / US
03 / Treiberg, Jennifer
19411 Grannis road
Bothell, WA 98012 / US
04 / Sowell, Gregory
9423 61st Avenue W.
Makilteo, WA 98275 / US
05 / Kesicki, Edward A.
2504 208th Place SE
Bothell, WA 98021 / US
06 / Oliver, Amy
3312 189th Place SE
Bothell, WA 98012 / US
 [2016/09]
Former [2010/35]01 / Sadhu, Chancal
903 223rd Street SE
Bothell, WA 98012 / US
02 / Dick, Ken
22517 1st Place West
Bothell, VA 98021-8321 / US
03 / Treiberg, Jennifer
19411 Grannis road
Bothell, WA 98012 / US
04 / Sowell, Gregory
9423 61st Avenue W.
Makilteo, WA 98275 / US
05 / Kesicki, Edward A.
2504 208th Place SE
Bothell, WA 98021 / US
06 / Oliver, Amy
3312 189th Place SE
Bothell, WA 98012 / US
Representative(s)Goodfellow, Hugh Robin, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2014/27]
Former [2013/22]Bailey, Sam Rogerson
Mewburn Ellis LLP
33 Gutter Lane
London
EC2V 8AS / GB
Former [2012/13]Barton, Matthew Thomas, et al
Forrester & Boehmert
SkyGarden
Erika-Mann-Strasse 11
80636 München / DE
Former [2010/35]Barton, Matthew Thomas
Forrester & Boehmert Pettenkoferstrasse 20-22
80336 München / DE
Application number, filing date10163434.324.04.2001
[2010/35]
Priority number, dateUS20000199655P25.04.2000         Original published format: US 199655 P
US20000238057P05.10.2000         Original published format: US 238057 P
[2010/35]
Previously filed application, dateEP2008000645724.04.2001
[2010/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2223922
Date:01.09.2010
Language:EN
[2010/35]
Type: A3 Search report 
No.:EP2223922
Date:27.04.2011
[2011/17]
Type: B1 Patent specification 
No.:EP2223922
Date:02.03.2016
Language:EN
[2016/09]
Search report(s)(Supplementary) European search report - dispatched on:EP29.03.2011
ClassificationIPC:C07D473/38, C07D473/34, C07D473/00, C07D473/24, C07D473/16, C07D473/40, C07D473/30, C07D403/12, C07D487/04, A61K31/517, A61K31/52, A61P7/00, A61P29/00, A61P19/10
[2011/17]
CPC:
C07D473/00 (EP,US); A61K31/52 (KR); A61P1/04 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P13/12 (EP); A61P17/00 (EP); A61P17/02 (EP);
A61P17/06 (EP); A61P19/00 (EP); A61P19/02 (EP);
A61P19/10 (EP); A61P21/00 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P31/04 (EP); A61P37/00 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P5/14 (EP); A61P7/00 (EP); A61P9/00 (EP);
A61P9/10 (EP); C07D403/12 (EP,US); C07D473/16 (EP,US);
C07D473/24 (EP,US); C07D473/30 (EP,US); C07D473/34 (EP,US);
C07D473/38 (EP,US); C07D473/40 (EP,US); C07D487/04 (EP,US) (-)
Former IPC [2010/35]C07D473/00, C07D473/16, C07D473/24, C07D473/30, C07D473/34, C07D473/38, C07D473/40, A61K31/517, A61K31/52, A61P19/10, A61P35/00
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2016/09]
Former [2010/35]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
Extension statesAL20.05.2010
LT20.05.2010
LV20.05.2010
MK20.05.2010
RO20.05.2010
SI20.05.2010
TitleGerman:Hemmer der menschlichen Phosphatidyl-inositol-3-kinase delta[2010/35]
English:Inhibitors of human phosphatidyl-inositol 3-kinase delta[2010/35]
French:Inhibiteurs delta de phosphatidyl-inositol 3-kinase humaine[2010/35]
Examination procedure20.05.2010Examination requested  [2010/35]
13.10.2011Amendment by applicant (claims and/or description)
25.03.2015Communication of intention to grant the patent
04.08.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
19.08.2015Communication of intention to grant the patent
15.12.2015Fee for grant paid
15.12.2015Fee for publishing/printing paid
15.12.2015Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP01928855.4  / EP1278748
EP08006457.9  / EP1939203
Divisional application(s)EP15200992.4  / EP3029041
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010928855) is  13.07.2004
Opposition(s)05.12.2016No opposition filed within time limit [2017/06]
Fees paidRenewal fee
20.05.2010Renewal fee patent year 03
20.05.2010Renewal fee patent year 04
20.05.2010Renewal fee patent year 05
20.05.2010Renewal fee patent year 06
20.05.2010Renewal fee patent year 07
20.05.2010Renewal fee patent year 08
20.05.2010Renewal fee patent year 09
20.05.2010Renewal fee patent year 10
12.04.2011Renewal fee patent year 11
28.03.2012Renewal fee patent year 12
29.04.2013Renewal fee patent year 13
28.04.2014Renewal fee patent year 14
27.04.2015Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US3322756  (HEINRICH RUSCHIG, et al) [A] 1,11-13,23,24* columns 7, 8, table; column 3, lines 43-45 *;
 [A]US3984555  (AMSCHLER HERMANN, et al) [A] 1,11-13,23,24 * claim 1; table VI *;
 [A]US4183931  (RATHMAN TERRY L [US], et al) [A] 1,11-13,23,24 * example 2; claim 4 *;
 [A]WO9417090  (GLAXO GROUP LTD [GB], et al) [A] 1,11-13,23,24 * page 1, line 3 - line 29; claims 1,14-16 *;
 [A]WO9604923  (PRO NEURON INC [US]) [A] 1,11-13,23,24 * claims 1-4,7,8 *;
 [A]WO9741097  (REDDY RESEARCH FOUNDATION [IN], et al) [A] 1,11-13,23,24 * examples 12-15,22,23,28,39-43; claims 1,17 *;
 [A]WO9833802  (UNIV NEWCASTLE VENTURES LTD [GB], et al) [A] 1,11-13,23,24 * claims 1,20,22 *;
 [A]WO9908501  (REDDY RESEARCH FOUNDATION [IN], et al) [A] 1,11-13,23,24 * examples 1-26,49-62; claims 1,25,26 *;
 [A]WO9934804  (UNIV VIRGINIA [US]) [A] 1,11-13,23,24 * claims 3,4 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.